Dr. Jamuna Rajasingham, M.D

NPI: 1073756474
Total Payments
$25,251
2024 Payments
$5,021
Companies
74
Transactions
1,060
Medicare Patients
3,177
Medicare Billing
$449,795

Payment Breakdown by Category

Food & Beverage$24,704 (97.8%)
Education$501.14 (2.0%)
Other$33.21 (0.1%)
Gifts$12.77 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $24,704 1,049 97.8%
Education $501.14 8 2.0%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $33.21 2 0.1%
Gift $12.77 1 0.1%

Top Paying Companies

Company Total Records Latest Year
Teva Pharmaceuticals USA, Inc. $5,475 286 $0 (2024)
ABBVIE INC. $2,463 119 $0 (2024)
EMD Serono, Inc. $1,752 56 $0 (2024)
Biogen, Inc. $1,411 41 $0 (2024)
Neurocrine Biosciences, Inc. $1,383 50 $0 (2024)
ACADIA Pharmaceuticals Inc $1,268 39 $0 (2024)
Allergan, Inc. $1,037 49 $0 (2022)
Novartis Pharmaceuticals Corporation $735.19 52 $0 (2024)
SK Life Science, Inc. $670.58 10 $0 (2024)
Celgene Corporation $492.83 26 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $5,021 198 Teva Pharmaceuticals USA, Inc. ($1,027)
2023 $5,215 202 Teva Pharmaceuticals USA, Inc. ($1,123)
2022 $3,898 158 Teva Pharmaceuticals USA, Inc. ($1,222)
2021 $3,134 166 Teva Pharmaceuticals USA, Inc. ($933.23)
2020 $1,592 101 Teva Pharmaceuticals USA, Inc. ($539.31)
2019 $2,484 109 EMD Serono, Inc. ($791.74)
2018 $1,127 43 Abbott Laboratories ($407.88)
2017 $2,780 83 Biogen, Inc. ($445.98)

All Payment Transactions

1,060 individual payment records from CMS Open Payments — Page 1 of 43

Date Company Product Nature Form Amount Type
12/17/2024 Amgen Inc. UPLIZNA (Biological) Food and Beverage In-kind items and services $35.00 General
Category: Inflammation/Rare Disease
12/17/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $18.61 General
Category: PSYCHIATRY
12/17/2024 Amgen Inc. UPLIZNA (Biological) Food and Beverage In-kind items and services $9.72 General
Category: Inflammation/Rare Disease
12/16/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $19.23 General
Category: PAIN
12/16/2024 Azurity Pharmaceuticals, Inc. HORIZANT (Drug) Food and Beverage In-kind items and services $16.68 General
Category: CEREBROVASCULARCNS
12/16/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $1.55 General
Category: PAIN
12/13/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $18.68 General
Category: Central Nervous System
12/10/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $16.78 General
Category: Neuropsychiatry
12/10/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $1.14 General
Category: Neuropsychiatry
12/06/2024 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $18.97 General
Category: Neuroscience
12/06/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $17.88 General
Category: Central Nervous System
12/05/2024 Amgen Inc. Food and Beverage In-kind items and services $110.82 General
12/03/2024 JAZZ PHARMACEUTICALS INC. XYWAV (Drug) Food and Beverage In-kind items and services $14.74 General
Category: NEUROLOGY
12/02/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $20.94 General
Category: PAIN
11/28/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $17.21 General
Category: Central Nervous System
11/26/2024 Amgen Inc. UPLIZNA (Biological) Food and Beverage In-kind items and services $8.46 General
Category: Inflammation/Rare Disease
11/22/2024 ARGENX US, INC. VYVGART HYTRULO (Drug) Food and Beverage In-kind items and services $20.45 General
Category: Neurology
11/22/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $17.69 General
Category: Central Nervous System
11/19/2024 Amgen Inc. UPLIZNA (Biological) Food and Beverage In-kind items and services $6.96 General
Category: Inflammation/Rare Disease
11/18/2024 Celgene Corporation ZEPOSIA (Drug) Food and Beverage Cash or cash equivalent $18.99 General
Category: Neuroscience
11/15/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $16.48 General
Category: Central Nervous System
11/12/2024 ABBVIE INC. BOTOX (Biological), QULIPTA Food and Beverage In-kind items and services $17.05 General
Category: BOTOX THERAPEUTIC
11/08/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $18.74 General
Category: Central Nervous System
11/06/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $16.49 General
Category: PAIN
11/06/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $2.77 General
Category: PAIN

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 11 837 1,200 $321,380 $123,999
2022 14 767 956 $276,785 $104,126
2021 14 790 972 $304,150 $116,914
2020 13 783 929 $283,025 $104,757
Total Patients
3,177
Total Services
4,057
Medicare Billing
$449,795
Procedure Codes
52

All Medicare Procedures & Services

52 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 242 466 $74,560 $31,672 42.5%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 184 194 $58,200 $20,721 35.6%
99291 Critical care, first 30-74 minutes Facility 2023 49 114 $55,290 $20,474 37.0%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 138 165 $37,950 $16,843 44.4%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 69 103 $33,475 $15,158 45.3%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 36 36 $16,560 $6,728 40.6%
95886 Needle measurement of electrical activity in arm or leg muscles, complete study Office 2023 39 42 $13,230 $3,583 27.1%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 20 20 $8,900 $2,871 32.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 29 29 $4,785 $2,267 47.4%
95910 Nerve conduction, 7-8 studies Office 2023 14 14 $9,590 $2,242 23.4%
95909 Nerve conduction, 5-6 studies Office 2023 17 17 $8,840 $1,440 16.3%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 161 168 $50,270 $19,297 38.4%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 80 123 $39,975 $17,967 44.9%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 173 262 $41,920 $16,094 38.4%
99291 Critical care, first 30-74 minutes Facility 2022 50 85 $41,225 $15,931 38.6%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 100 109 $25,070 $9,607 38.3%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 48 48 $22,080 $8,671 39.3%
95886 Needle measurement of electrical activity in arm or leg muscles, complete study Office 2022 41 43 $13,545 $4,053 29.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 35 36 $5,940 $2,980 50.2%
95910 Nerve conduction, 7-8 studies Office 2022 16 16 $10,960 $2,494 22.8%
95909 Nerve conduction, 5-6 studies Office 2022 16 16 $8,320 $2,072 24.9%
95911 Nerve conduction, 9-10 studies Office 2022 11 11 $9,020 $1,942 21.5%
99219 Initial hospital observation care per day, typically 50 minutes Facility 2022 13 13 $3,900 $1,388 35.6%
95885 Needle measurement of electrical activity in arm or leg muscles, limited study Office 2022 11 14 $2,940 $880.34 29.9%
99283 Emergency department visit for problem of moderate severity Facility 2022 12 12 $1,620 $749.53 46.3%

About Dr. Jamuna Rajasingham, M.D

Dr. Jamuna Rajasingham, M.D is a Neurology healthcare provider based in Englewood, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/14/2009. The National Provider Identifier (NPI) number assigned to this provider is 1073756474.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jamuna Rajasingham, M.D has received a total of $25,251 in payments from pharmaceutical and medical device companies, with $5,021 received in 2024. These payments were reported across 1,060 transactions from 74 companies. The most common payment nature is "Food and Beverage" ($24,704).

As a Medicare-enrolled provider, Rajasingham has provided services to 3,177 Medicare beneficiaries, totaling 4,057 services with total Medicare billing of $449,795. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.

Practice Information

  • Specialty Neurology
  • Location Englewood, NJ
  • Active Since 04/14/2009
  • Last Updated 07/21/2022
  • Taxonomy Code 2084N0400X
  • Entity Type Individual
  • NPI Number 1073756474

Products in Payments

  • AJOVY (Biological) $1,617
  • Austedo XR (Drug) $1,489
  • AUSTEDO (Drug) $1,322
  • NUPLAZID (Drug) $1,163
  • INGREZZA (Drug) $1,013
  • BOTOX (Biological) $951.55
  • UBRELVY (Drug) $942.86
  • Mavenclad (Biological) $780.49
  • ZEPOSIA (Drug) $768.22
  • TYSABRI (Biological) $714.15
  • QULIPTA (Drug) $580.07
  • NURTEC ODT (Drug) $493.90
  • Hizentra (Biological) $480.04
  • KESIMPTA (Drug) $447.03
  • Infinity DBS Pulse Generators (Device) $445.20
  • XCOPRI (Drug) $438.42
  • COPAXONE (Drug) $436.66
  • REXULTI (Drug) $378.66
  • Duopa (Drug) $311.48
  • Leqembi (Drug) $309.67

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Neurology Doctors in Englewood